Avilar Therapeutics
Waltham
About Avilar Therapeutics
Avilar Therapeutics is a biopharmaceutical company focusing on the discovery and development of extracellular protein degraders, a new frontier in targeted protein degradation.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $50K – $100K
- Total funding: $75.0M
- Funding stage: Seed
- Last round: Seed (Feb 2023)
- Website: avilar-tx.com
Industries & Categories
Biotechnology, Medical, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/avilar-therapeutics-50334 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.